中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2014年
20期
168-169,172
,共3页
重组人表皮生长因子%鼻咽癌%预防%防放射性口咽炎
重組人錶皮生長因子%鼻嚥癌%預防%防放射性口嚥炎
중조인표피생장인자%비인암%예방%방방사성구인염
The reorganization human epidermi growth factor%Nasopharyngeal carcinoma%Prevent%Radio oropharyngeal
目的:探讨重组人表皮生长因子在鼻咽癌放疗中预防放射性口咽炎的临床疗效。方法按照随机数字表法将本治疗组收治的64例鼻咽癌患者均分为实验组和对照组,实验组患者在放疗基础上加用重组人表皮生长因子口腔喷雾治疗,对照组患者在放疗基础上加用复方漱口液治疗,比较两组患者放射性口咽炎发生情况以及发生放射性口咽炎时平均放射剂量。结果实验组患者Ⅱ级+Ⅲ级放射性口咽炎发生率显著低于对照组,差异具有统计学意义(P<0.05);实验组患者发生Ⅰ级、Ⅱ级和Ⅲ级放射性口咽炎时平均放射剂量均显著高于对照组,差异具有统计学意义(P<0.05)。结论重组人表皮生长因子能够有效预防鼻咽癌放疗中放射性口咽炎的发生,提高患者放疗剂量的耐受性,临床疗效显著。
目的:探討重組人錶皮生長因子在鼻嚥癌放療中預防放射性口嚥炎的臨床療效。方法按照隨機數字錶法將本治療組收治的64例鼻嚥癌患者均分為實驗組和對照組,實驗組患者在放療基礎上加用重組人錶皮生長因子口腔噴霧治療,對照組患者在放療基礎上加用複方漱口液治療,比較兩組患者放射性口嚥炎髮生情況以及髮生放射性口嚥炎時平均放射劑量。結果實驗組患者Ⅱ級+Ⅲ級放射性口嚥炎髮生率顯著低于對照組,差異具有統計學意義(P<0.05);實驗組患者髮生Ⅰ級、Ⅱ級和Ⅲ級放射性口嚥炎時平均放射劑量均顯著高于對照組,差異具有統計學意義(P<0.05)。結論重組人錶皮生長因子能夠有效預防鼻嚥癌放療中放射性口嚥炎的髮生,提高患者放療劑量的耐受性,臨床療效顯著。
목적:탐토중조인표피생장인자재비인암방료중예방방사성구인염적림상료효。방법안조수궤수자표법장본치료조수치적64례비인암환자균분위실험조화대조조,실험조환자재방료기출상가용중조인표피생장인자구강분무치료,대조조환자재방료기출상가용복방수구액치료,비교량조환자방사성구인염발생정황이급발생방사성구인염시평균방사제량。결과실험조환자Ⅱ급+Ⅲ급방사성구인염발생솔현저저우대조조,차이구유통계학의의(P<0.05);실험조환자발생Ⅰ급、Ⅱ급화Ⅲ급방사성구인염시평균방사제량균현저고우대조조,차이구유통계학의의(P<0.05)。결론중조인표피생장인자능구유효예방비인암방료중방사성구인염적발생,제고환자방료제량적내수성,림상료효현저。
Objective To explore the preventive effect of the reorganization human epidermis growth factor in the prevention of radioactive oropharyngeal in the radiotherapy of nasopharyngeal carcinoma. Methods 64 cases of patients with nasopharyngeal carcinoma were randomly divided into experiment group and control group.On the basis of radiotherapy,the experiment group were treated by reorganization human epidermis growth factor,the control group were treated by mouthwashes.The happening of radio oropharyngeal and the average dose when radio oropharyngeal happened were compared in the two groups. Results The occurrence rate of II+III radio oropharyngeal in the experiment group was lower than the control group(P<0.05);The average dose when radio oropharyngeal happened in the experiment group were higher than the control group(P<0.05). Conclusion Reorganization human epidermal growth factor can effectively prevent the happening of the radioactive oropharyngeal in nasopharyngeal carcinoma radiotherapy,it can increase the tolerance of radiological dose for the patients.The clinical curative effect is distinct.